The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo ...
This biotech develops therapies for neurodegenerative diseases, advancing a broad pipeline through strategic pharmaceutical ...
Researchers from the University of California San Diego found that prescriptions for leucovorin, a drug sometimes used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results